Join us Dec. 1-3 in Nashville for the Digiday Programmatic Marketing Summit
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Post World Cup, fashion brands are tapping soccer stars like Bellingham and Yamal for partnerships
Three months after the World Cup ended in a Spanish victory, the partnerships with marquee players keep coming.
How Lush quit social media ads and still drove growth
Quitting Meta, TikTok and X seemed like a gamble, but Lush was returning to its marketing roots. The results reshaped their entire approach.
In Graphic Detail: What Apple’s identity block means for the ad money
How Apple’s identity block hits publishers’ wallets, and why Apple can afford it.